(Q51751812)
Statements
A randomized phase 2 trial of bevacizumab with or without daily low-dose interferon alfa-2b in metastatic malignant melanoma. (English)
1 reference
Kimberly A Varker
1 reference
Jennifer E Biber
1 reference
Cheryl Kefauver
1 reference
Rhonda Jensen
1 reference
Amy Lehman
1 reference
Donn Young
1 reference
Haifeng Wu
1 reference
Gregory B Lesinski
1 reference
Kari Kendra
1 reference
Helen X Chen
1 reference
Michael J Walker
1 reference
William E Carson
1 reference
30 May 2007
1 reference
14
1 reference
8
1 reference
2367-2376
1 reference
1 reference
1 reference
Identifiers
1 reference